Reed Jost
May 8, 2016
Related Articles
Phase III Treatment Trial for Stargardt Disease Enrolls First Patient Recently@Retina Newsletter April 2023 Retina Foundation is Major Center for Next Phase of Gene Therapy for X-Linked Retinitis Pigmentosa: SKYLINE Promising Results From Ongoing Phase 1/2 Clinical Trial for X-Linked Retinitis Pigmentosa (XLRP) Retina Foundation to Conduct First Optogenetics Gene Therapy Clinical Trial